Your browser doesn't support javascript.
loading
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
Piñana, José Luis; Vazquez, Lourdes; Calabuig, Marisa; López-Corral, Lucia; Martin-Martin, Gabriel; Villalon, Lucia; Sanz-Linares, Gabriela; Conesa-Garcia, Venancio; Sanchez-Salinas, Andrés; Gago, Beatriz; Facal, Ana; Risco-Gálvez, Irene; Olave, María T; Espigado, Ildefonso; Lopez-Jimenez, Javier; Hernández-Rivas, José Ángel; Avendaño-Pita, Alejandro; Arroyo, Ignacio; Ferrer, Elena; García-Cadenas, Irene; González-Santillana, Clara; Roldán-Pérez, Alicia; Ferrer, Blanca; Guerreiro, Manuel; Suarez-Lledó, María; Camara, Angela; Campos-Beltrán, Diana; Navarro, David; Cedillo, Ángel; Sureda, Anna; Solano, Carlos; Martino, Rodrigo.
Afiliação
  • Piñana JL; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain. jlpinana@gmail.com.
  • Vazquez L; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain. jlpinana@gmail.com.
  • Calabuig M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
  • López-Corral L; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Martin-Martin G; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Villalon L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
  • Sanz-Linares G; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
  • Conesa-Garcia V; Hematology Division, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Sanchez-Salinas A; Hematology Division, Institut Català Oncologia-Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Gago B; Hematology Division, Hospital General universitario de Elche, Elche, Spain.
  • Facal A; Hematology Division, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Risco-Gálvez I; Hematology Division, Hospital Regional Universitario Carlos Haya, Malaga, Spain.
  • Olave MT; Hematology Division, Hospital universitario y politécnico La Fe, Valencia, Spain.
  • Espigado I; Hematology Division, Hospital Arnau de Vilanova, Valencia, Spain.
  • Lopez-Jimenez J; Hematology Division, Hospital Clínico Universitario Lozano Blesa, IIS Aragon, Zaragoza, Spain.
  • Hernández-Rivas JÁ; Hematology Division, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Avendaño-Pita A; Hematology Division, Hospital Ramon y Cajal, Madrid, Spain.
  • Arroyo I; Hematology Division, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Ferrer E; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
  • García-Cadenas I; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • González-Santillana C; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Roldán-Pérez A; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Ferrer B; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Guerreiro M; Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Suarez-Lledó M; Hematology Division, Hospital de Fuenlabrada, Madrid, Spain.
  • Camara A; Hematology división, Hospital Infanta Sofia, Madrid, Spain.
  • Campos-Beltrán D; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Navarro D; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Cedillo Á; Hematology Division, Hospital universitario y politécnico La Fe, Valencia, Spain.
  • Sureda A; Hematology Division, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Solano C; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Martino R; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Blood Cancer J ; 13(1): 8, 2023 01 05.
Article em En | MEDLINE | ID: mdl-36599843
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article